Procter & Gambleの空売り状況は、投資家がProcter & Gambleの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Procter & Gamble (NYSE:PG) 株価情報, 空売り情報

Procter & Gamble

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

ISRG

NFLX

アメリカの株先物は金曜日の朝、低い動きを見せており、投資家の動きも慎重になっている。ウォール街は、オープニングベルの前に、The Procter &amp; Gamble Company（NYSE:PG）が1株あたり1.41ドル、225.41億ドルの売上で四半期決算を発表すると見込んでいます。これはBenzinga Proのデータより明らかになっています。Procter &amp; Gambleの株は、アフターセッションで157.14ドルに0.1％の下落となった。Intuitive Surgical Inc（NASDAQ:ISRG）は、木曜日に第1四半期の決算を予想を上回る結果を発表しました。インチュイティブ・サージカルの株はアフターセッションで3.5％上昇し、385.60ドルで取引されている。アナリストは、American Express Company（NYSE:AXP）が純利益2.95ドル、157.9億ドルの売上で四半期決算を発表すると予想しています。同社は市場がオープンする前に決算を発表します。アメリカン・エキスプレスの株はアフターセッションで、213.90ドルに1.7％下落を記録した。こちらのプレマーケットのカバレッジをチェックNetflix Inc（NASDAQ:NFLX）は第1四半期の楽観的な決算と売上の結果を発表しました。同社は第1四半期に933万人の有料会員を追加し、合計2億6960万人の会員数になりました。Netflixの株はアフターセッションで4.8％下落し、581.49ドルで取引されている。アナリストは、Schlumberger Limited（NYSE:SLB）がオープニングベルの前に1株あたり75セントの四半期利益を、86.9億ドルの売上で発表すると予想しています。SLBの株はアフターセッションで0.5％下落し、50.69ドルで取引されている。

「Netflix（ネットフリックス）、Procter＆Gamble（プロクター＆ギャンブル）」金曜日に注目すべき株式

Procter & Gamble Company (The) Common Stock

Procter & Gamble Co

PGI Inc

Global X Funds Global X MSCI Portugal ETF

Petrogress Inc

PPB Group Bhd

Peapack-Gladstone Financial Corporation - Common Stock

Peapack Gladstone Financial Corp

PUREGOLD PRICE CLUB INC by Puregold Price Club Inc.

Puregold Price Club Inc

PTT Global Chemical PCL Units Non-Voting Depository Receipts

PTT Global Chemical PCL

PROSEGUR CIA DE SECURIDAD by Prosegur Cia De Securidad SA

Prosegur Compania De Seguridad SA

PGD ECO SOLUTIONS INC by PGD ECO SOLUTIONS INC.

PGD Eco Solutions Inc

PGS ASA

Precigen Inc

Pigeon Corp

STILLWATER CRITICAL MNRLS by STILLWATER CRITICAL MINERALS CORP.

Stillwater Critical Minerals Corp

Invesco Financial Preferred ETF

PIONEER GREEN FARMS INC by PIONEER GREEN FARMS INC.

Pioneer Green Farms Inc

PINGIFY INTERNATIONAL INC by Pingify International Inc.

Pingify International Inc

PIAGGIO & C SPA UNSP/ADR by Piaggio & C Spa Pontedera

Piaggio & C. SpA

PEGASUS GAMING CORP by Pegasus Gaming Corp.

Primega Group Holdings Limited - Ordinary Shares

Primega Group Holdings Ltd

Invesco Global ex-US High Yield Corporate Bond ETF

PEREGRINE INDUS INC by Peregrine Industries, Inc.

Peregrine Industries Inc

PGI Energy Inc

PRESTIGE INTL INC (JAPAN) by Prestige International Inc.

Prestige International Inc

Invesco Golden Dragon China ETF

P2 Gold Inc

PRIMEGEN ENERGY CORP by Primegen Energy Corp.

Primegen Energy Corp

PARAGON FINCL SLTNS INC by Paragon Financial Solutions, Inc. (TN)

Paragon Financial Solutions Inc

Pan Global Resources Inc

PARAGON TECHS INC by Paragon Technologies, Inc.

Paragon Technologies Inc

Progyny Inc

Hartshead Resources NL

PERF-GO-GREEN HLDGS INC by PERF Go-Green Holdings, Inc.

PERF Go-Green Holdings Inc

Patriot Gold Corp

Pimco Global StocksPlus & Income Fund Common Shares of Beneficial Interest

PIMCO Global Stocksplus & Income Fund

PUBLICIS GROUPE ACT by Publicis Groupe S.A.

Publicis Groupe SA

Power Group Projects Corp

POWER GROUP PROJECTS CORP by Power Group Projects Corp.

PARTNERS GRP HLDG ZUG by Partners Group Holding Zug Namen-Akt

Partners Group Holding AG

PGE POLSKA ENERG UNSP/ADR by PGE Polska Energetyczna SA

Polska Grupa Energetyczna SA

PILGRIM PETROLEUM CORP by Pilgrim Petroleum Corp.

Pilgrim Petroleum Corp

First Lithium Minerals Corp

Progressive Corporation (The) Common Stock

Progressive Corp

Paramount Group Inc

Putnam Focused Large Cap Growth ETF

PropertyGuru Group Limited Ordinary Shares

PropertyGuru Group Ltd

PROGRESSIVE GREEN SOL INC by Progressive Green Solutions, Inc.

PEGASUS DIGITAL MOBILITY ACQUISITION CORP CL A ORD SHS

PGT INC COM

PACIFIC GREEN TECHS by Pacific Green Technologies Inc.

Pacific Green Technologies Inc

Pegatron Corp

Prosegur Cash SA

KK PASONA GROUP INC by KK Pasona Group Inc.

Pasona Group Inc

PROMITHIAN GLBL VNTR INC by Promithian Global Ventures, Inc.

Promithian Global Ventures Inc

PGG Wrightson Ltd

Invesco Preferred ETF

Prosper Gold Corp

PELANGIO EXPLORATION by Pelangio Exploration Inc.

Pelangio Exploration Inc

Pagaya Technologies Ltd. - Class A Ordinary Shares

Pagaya Technologies Ltd

PATRIOT ENERGY CORP DE by Patriot Energy Corp.

Patriot Energy Corp

Principal Real Estate Income Fund Common Shares of Beneficial Interest

Principal Real Estate Income Fund

PAN GLOBAL RESOURCE INC by Pan Global Resource, Inc.

Wells Fargo analyst Chris Carey maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Overweight and raises the price target from $188 to $190.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Procter & Gamble, Raises Price Target to $190

In the last three months, 11 analysts have published ratings on Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Procter &amp; Gamble, revealing an average target of $171.73, a high estimate of $191.00, and a low estimate of $159.00. Surpassing the previous average price target of $167.25, the current average has increased by 2.68%.
<img src="https://www.benzinga.com/files/images/story/2024/1732125637_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Procter &amp; Gamble. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$191.00</td>
<td>$174.00</td>
</tr>
<tr>
<td>Robert Ottenstein</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$183.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$159.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$159.00</td>
<td>-</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Neutral</td>
<td>$174.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$186.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Michael Pohn</td>
<td>DZ Bank</td>
<td>Announces</td>
<td>Buy</td>
<td>$190.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Procter &amp; Gamble. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Procter &amp; Gamble compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Procter &amp; Gamble's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Procter &amp; Gamble's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Procter &amp; Gamble analyst ratings.</a>
<h2>About Procter &amp; Gamble</h2>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
<h3>Understanding the Numbers: Procter &amp; Gamble's Finances</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Procter &amp; Gamble's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -0.61%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Procter &amp; Gamble's net margin excels beyond industry benchmarks, reaching 17.88%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Procter &amp; Gamble's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 7.73%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Procter &amp; Gamble's ROA excels beyond industry benchmarks, reaching 3.12%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.71, Procter &amp; Gamble adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

11 Analysts Have This To Say About Procter & Gamble

DA Davidson analyst Linda Bolton Weiser maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Neutral and maintains $160 price target.

DA Davidson Maintains Neutral on Procter & Gamble, Maintains $160 Price Target

Politics

General

Unilever, Procter & Gamble Face Risk From Trump's Threatened Mexico Tariffs

In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry out an in-depth industry comparison, assessing Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) alongside its primary competitors in the Household Products industry. By meticulously examining key financial metrics, market positioning, and growth prospects, we aim to offer valuable insights to investors and shed light on company's performance within the industry.
<h3>Procter &amp; Gamble Background</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Procter &amp; Gamble Co</td>
<td>28.65</td>
<td>7.67</td>
<td>4.89</td>
<td>6.2%</td>
<td>$4.85</td>
<td>$10.18</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Colgate-Palmolive Co</td>
<td>27.20</td>
<td>177.79</td>
<td>3.88</td>
<td>414.16%</td>
<td>$1.25</td>
<td>$3.07</td>
<td>4.89%</td>
</tr>
<tr>
<td>Kimberly-Clark Corp</td>
<td>17.41</td>
<td>34.88</td>
<td>2.26</td>
<td>74.93%</td>
<td>$1.35</td>
<td>$1.78</td>
<td>-3.51%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co Inc</td>
<td>31.02</td>
<td>5.72</td>
<td>4.14</td>
<td>5.79%</td>
<td>$0.4</td>
<td>$0.71</td>
<td>3.92%</td>
</tr>
<tr>
<td>Clorox Co</td>
<td>69.56</td>
<td>59.01</td>
<td>2.75</td>
<td>103.1%</td>
<td>$0.35</td>
<td>$0.88</td>
<td>-5.75%</td>
</tr>
<tr>
<td>Reynolds Consumer Products Inc</td>
<td>15.82</td>
<td>2.82</td>
<td>1.58</td>
<td>4.82%</td>
<td>$0.17</td>
<td>$0.26</td>
<td>-1.06%</td>
</tr>
<tr>
<td>WD-40 Co</td>
<td>51.77</td>
<td>15.54</td>
<td>6.08</td>
<td>7.39%</td>
<td>$0.03</td>
<td>$0.08</td>
<td>11.06%</td>
</tr>
<tr>
<td>Spectrum Brands Holdings Inc</td>
<td>23.08</td>
<td>1.22</td>
<td>1.21</td>
<td>0.28%</td>
<td>$0.08</td>
<td>$0.3</td>
<td>5.97%</td>
</tr>
<tr>
<td>Energizer Holdings Inc</td>
<td>232.07</td>
<td>18.90</td>
<td>0.81</td>
<td>-27.84%</td>
<td>$0.01</td>
<td>$0.28</td>
<td>0.29%</td>
</tr>
<tr>
<td>Central Garden &amp; Pet Co</td>
<td>13.51</td>
<td>1.24</td>
<td>0.60</td>
<td>5.14%</td>
<td>$0.14</td>
<td>$0.32</td>
<td>-2.63%</td>
</tr>
<tr>
<td>Oil-Dri Corp of America</td>
<td>12.55</td>
<td>2.36</td>
<td>1.38</td>
<td>3.08%</td>
<td>$0.02</td>
<td>$0.03</td>
<td>5.88%</td>
</tr>
<tr>
<td>Average</td>
<td>49.4</td>
<td>31.95</td>
<td>2.47</td>
<td>59.09%</td>
<td>$0.38</td>
<td>$0.77</td>
<td>1.91%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By closely examining Procter &amp; Gamble, we can identify the following trends: 
<ul>
<li>
The Price to Earnings ratio of 28.65 is 0.58x lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
With a Price to Book ratio of 7.67, significantly falling below the industry average by 0.24x, it suggests undervaluation and the possibility of untapped growth prospects.
</li>
<li>
The Price to Sales ratio of 4.89, which is 1.98x the industry average, suggests the stock could potentially be overvalued in relation to its sales performance compared to its peers.
</li>
<li>
The company has a lower Return on Equity (ROE) of 6.2%, which is 52.89% below the industry average. This indicates potential inefficiency in utilizing equity to generate profits, which could be attributed to various factors.
</li>
<li>
With higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $4.85 Billion, which is 12.76x above the industry average, the company demonstrates stronger profitability and robust cash flow generation.
</li>
<li>
The company has higher gross profit of $10.18 Billion, which indicates 13.22x above the industry average, indicating stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of -0.1% is significantly below the industry average of 1.91%. This suggests a potential struggle in generating increased sales volume.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730386834_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is a measure that indicates the level of debt a company has taken on relative to the value of its assets net of liabilities.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
By evaluating Procter &amp; Gamble against its top 4 peers in terms of the Debt-to-Equity ratio, the following observations arise:
<ul>
<li>
Procter &amp; Gamble demonstrates a stronger financial position compared to its top 4 peers in the sector.
</li>
<li>
With a lower debt-to-equity ratio of 0.67, the company relies less on debt financing and maintains a healthier balance between debt and equity, which can be viewed positively by investors.
</li>
</ul>
<h3>Key Takeaways</h3>
The PE, PB, and PS ratios for Procter &amp; Gamble indicate that it is undervalued compared to its peers in the Household Products industry. However, the low ROE suggests that the company is not efficiently utilizing its assets to generate profits. On the other hand, the high EBITDA and gross profit margins highlight strong operational performance. The low revenue growth rate may be a concern for the company's future prospects in the industry.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Performance Comparison: Procter &amp; Gamble And Competitors In Household Products Industry

Financial giants have made a conspicuous bearish move on Procter &amp; Gamble. Our analysis of options history for Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) revealed 8 unusual trades.
Delving into the details, we found 37% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $486,322, and 2 were calls, valued at $76,343.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $160.0 to $195.0 for Procter &amp; Gamble during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Procter &amp; Gamble options trades today is 230.4 with a total volume of 1,138.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Procter &amp; Gamble's big money trades within a strike price range of $160.0 to $195.0 over the last 30 days.
<h3>Procter &amp; Gamble Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729799142_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.7</td>
<td>$10.5</td>
<td>$10.7</td>
<td>$170.00</td>
<td>$256.8K</td>
<td style="text-align: right;">289</td>
<td style="text-align: right;">256</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.25</td>
<td>$13.0</td>
<td>$13.0</td>
<td>$175.00</td>
<td>$78.0K</td>
<td style="text-align: right;">319</td>
<td style="text-align: right;">83</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.2</td>
<td>$13.0</td>
<td>$13.0</td>
<td>$175.00</td>
<td>$52.0K</td>
<td style="text-align: right;">319</td>
<td style="text-align: right;">128</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$8.65</td>
<td>$8.55</td>
<td>$8.55</td>
<td>$170.00</td>
<td>$43.5K</td>
<td style="text-align: right;">280</td>
<td style="text-align: right;">51</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$1.71</td>
<td>$1.69</td>
<td>$1.69</td>
<td>$167.50</td>
<td>$38.5K</td>
<td style="text-align: right;">289</td>
<td style="text-align: right;">279</td>
</tr>
</tbody>
</table>

<h3>About Procter &amp; Gamble</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
In light of the recent options history for Procter &amp; Gamble, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Procter &amp; Gamble</h3>
<ul>
<li>With a trading volume of 3,232,922, the price of PG is down by -0.15%, reaching $169.33.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 89 days from now.</li>
</ul>
<h3>Expert Opinions on Procter &amp; Gamble</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $172.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Barclays downgraded its rating to Equal-Weight, setting a price target of $163. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Procter &amp; Gamble, which currently sits at a price target of $191. 
&#x2A; An analyst from DA Davidson has decided to maintain their Neutral rating on Procter &amp; Gamble, which currently sits at a price target of $160. 
&#x2A; An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Procter &amp; Gamble, which currently sits at a price target of $183. 
&#x2A; An analyst from RBC Capital has revised its rating downward to Sector Perform, adjusting the price target to $164. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Procter &amp; Gamble with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Unpacking the Latest Options Trading Trends in Procter & Gamble

Kenvue Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) shares are moving higher Monday following a report suggesting activist investor Starboard Value has acquired <a href="https://www.benzinga.com/markets/equities/24/10/41419988/tylenol-listerine-maker-kenvue-under-activist-spotlight-with-starboard-value-stake-overhaul-ahea">a stake in the company</a>. 
The Details: According to the <a href="https://www.wsj.com/business/deals/activist-starboard-value-takes-stake-in-tylenol-maker-kenvue-cc3175bb">Wall Street Journal</a>, Starboard has acquired a &#8220;sizable&#8221; stake in Kenvue and is pushing for changes to boost the consumer-products company&#8217;s share price. The activist investor asserts that Kenvue has &#8220;some of the best consumer brands,&#8221; yet its stock has lagged behind its competitors for over a year.
Kenvue&#8217;s iconic brands include Aveeno, BAND-AID Brand, Johnson&#8217;s, Listerine, Neutrogena and Tylenol. Kenvue shares are up just 7% year-to-date compared to more than 23% gains in the S&amp;P 500. Competitors Haleon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLN#NYSE">HLN</a>) and Proctor and Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) have climbed 21% and 16%, respectively, since the start of the year.
The exact size of Starboard's position in Kenvue was not shared. Starboard&#8217;s specific turnaround ideas were also not reported, but people familiar with the matter said Starboard CEO Jeff Smith is expected to discuss more about Starboard&#8217;s perspective on Kenvue at the 13D Monitor Active-Passive Investor Summit in New York on Tuesday. 
According to a separate <a href="https://www.msn.com/en-us/money/companies/activist-starboard-could-push-for-kenvue-to-sell-some-all-of-its-sbh-business-analyst/ar-AA1sEH3C?ocid=finance-verthp-feeds">report</a>, Starboard may try to push the company to sell its skin, healthcare and beauty division in whole or part.
In a note released Monday, JPMorgan analyst Andrea Teixeira said, &#8220;Given the SHB segment has been a key area of debate on the stock over the past year and a half, we would expect Starboard to detail changes it would like to see management make to this division — which we suspect could involve divesting some/all of the segment.&#8221;
Kenvue was spun out of Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) last year. The company currently has a market cap of more than $41 billion, according to data from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Related Link: <a href="https://www.benzinga.com/news/24/10/41417197/elon-musk-tesla-refute-inefficiency-concerns-with-wireless-charging-on-cybercab-there-is-no-meaningf">Elon Musk, Tesla Refute Inefficiency Concerns With Wireless Charging On Cybercab: &#8216;There Is No Meaningful Efficiency Difference…&#8217;</a>
KVUE Price Action: At the time of publication, Kenvue stock was up 5.96% at $23.02, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: 3972315 from Pixabay.

Movers

KVUE

What's Going On With Kenvue Stock Monday?

Morgan Stanley analyst Dara Mohsenian maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Overweight and raises the price target from $174 to $191.

Morgan Stanley Maintains Overweight on Procter & Gamble, Raises Price Target to $191

On Friday, Procter &amp; Gamble Co (NYSE: PG) reported <a href="https://www.benzinga.com/news/earnings/24/10/41400657/procter-gambles-mixed-bag-q1-eps-exceeds-estimates-reaffirms-growth-outlook-more">mixed results for its fiscal first quarter</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
DA Davidson On Procter &amp; Gamble
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5890a92043eaaa0001d69b01/linda-bolton%20weiser">Analyst Linda Bolton Weiser</a> maintained a Neutral rating and raised the price target from $159 to $160.
Procter &amp; Gamble reported quarterly sales of $21.737 billion, down 6% and below consensus of $21.977 billion, Bolton Weiser said in a note. Earnings came in at $1.93 per share, beating the consensus of $1.90 per share, backed by a lower tax rate and higher non-operating income versus expectations, she added.
Management maintained their sales and earnings guidance, the analyst stated. "PG believes organic sales growth should improve in F2H25 due to more innovation and annualizing the negative impacts (China, SK-II, Middle East) that started in F2H24," she further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
RBC Capital Markets On Procter &amp; Gamble
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/589dc34043eaaa000122c5a2/nik-modi">Analyst Nik Modi</a> reiterated a Sector Perform rating and price target of $164.
Topline concerns heading into the print came to fruition due to the volatility of markets such as China and the Middle East," Modi wrote. He added that despite the sales miss, Procter &amp; Gamble delivered flat gross margins, partially offset by commodity costs, product and package reinvestment, and currency impact.
The company's volume trajectory in many of its key markets remained strong, the analyst stated. "We believe the biggest debate for investors regarding guidance concerns whether PG can maintain performance in the 85% of sales base that is doing well given the macro drags on the remaining 15%," he further said.
Truist Securities On Procter &amp; Gamble
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59e8ba80efacff0001417468/patrick-scholes">Analyst Bill Chappell</a> reiterated a Buy rating and price target of $175.
Procter &amp; Gamble's results and call were broadly in-line with expectations, Chappell said. "The company faced continued weakness in China as SK-II sales dragged down sales 15% in China and 20% in company-level Skin Care," he wrote.
The analyst also stated that headwinds in the Middle East negatively impacted the quarter. Going by the latest results, Procter &amp; Gamble appears on track to meet the midpoint of its full-year guide, and future volatility in results is likely to be "China-driven," he added.
PG Price Action: Shares of Procter &amp; Gamble were down 1.56% to $168.60 at the time of publication on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41431406/elon-musk-says-tesla-will-not-buy-ev-rival-rivian-going-to-have-a-hard-time">Elon Musk Says Tesla Will Not Buy EV Rival Rivian: &#8216;Going To Have A Hard Time&#8217;</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings Beats

Reiteration

Procter & Gamble Reports Q1 Earnings Beat, But Analysts Highlight Ongoing Concerns Over China Impact

Evercore ISI Group analyst Robert Ottenstein maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Outperform and raises the price target from $180 to $183.

Evercore ISI Group Maintains Outperform on Procter & Gamble, Raises Price Target to $183

RBC Capital analyst Nik Modi reiterates Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Sector Perform and maintains $164 price target.

RBC Capital Reiterates Sector Perform on Procter & Gamble, Maintains $164 Price Target

In the latest quarter, 11 analysts provided ratings for Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $170.18, along with a high estimate of $190.00 and a low estimate of $159.00. Marking an increase of 0.55%, the current average surpasses the previous average price target of $169.25. 
<img src="https://www.benzinga.com/files/images/story/2024/1729515654_0_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of Procter &amp; Gamble by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$159.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$159.00</td>
<td>-</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Neutral</td>
<td>$174.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$186.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Michael Pohn</td>
<td>DZ Bank</td>
<td>Announces</td>
<td>Buy</td>
<td>$190.00</td>
<td>-</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$163.00</td>
<td>$174.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$179.00</td>
<td>$181.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$164.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$175.00</td>
<td>$182.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Procter &amp; Gamble. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Procter &amp; Gamble compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Procter &amp; Gamble's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Procter &amp; Gamble's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Procter &amp; Gamble analyst ratings.</a>
<h2>All You Need to Know About Procter &amp; Gamble</h2>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
<h3>Understanding the Numbers: Procter &amp; Gamble's Finances</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Challenges: Procter &amp; Gamble's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.1%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Procter &amp; Gamble's net margin is impressive, surpassing industry averages. With a net margin of 14.91%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Procter &amp; Gamble's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 6.2%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Procter &amp; Gamble's ROA stands out, surpassing industry averages. With an impressive ROA of 2.53%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Procter &amp; Gamble's debt-to-equity ratio is below the industry average. With a ratio of 0.67, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 11 Analyst Projections For Procter & Gamble

DA Davidson analyst Linda Bolton Weiser maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Neutral and raises the price target from $159 to $160.

DA Davidson Maintains Neutral on Procter & Gamble, Raises Price Target to $160

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index moved to the &#8220;Extreme Greed&#8221; zone on Friday.
U.S. stocks settled higher on Friday, with the Dow Jones index and S&amp;P 500 jumping to fresh record highs during the session.
All three major indices recorded gains for the sixth straight week, with the Dow and S&amp;P 500 gaining 0.96% and 0.85%, respectively. The Nasdaq, meanwhile, added 0.80% last week.
On the economic data front, U.S. housing starts fell by 0.5% from the previous month to an annualized rate of 1.354 million units in September. Building permits declined by 2.9% to an annual rate of 1.428 million in September.
Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) shares jumped around 11% on Friday after the company reported better-than-expected third-quarter earnings. The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) posted upbeat quarterly earnings, while revenue missed estimates.
As far as the earnings season is concerned, over 70 S&amp;P 500 companies have released quarterly results so far, with around 75% of those exceeding market estimates.
Most sectors on the S&amp;P 500 closed on a positive note, with utilities, communication services, and real estate stocks recording the biggest gains on Friday. However, energy stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 37 points to 43,275.91 on Friday. The S&amp;P 500 gained 0.40% to rise to 5,864.67, while the Nasdaq Composite rose 0.63% to close at 18,489.55 during Friday's session.
Investors are awaiting earnings results from SAP SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>), Nucor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>), and Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 75, the index moved to the &#8220;Extreme Greed&#8221; zone on Friday, versus a prior reading of 70.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41402086/wall-streets-most-accurate-analysts-give-their-take-on-3-financials-stocks-delivering-hi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Financials Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

LOGI

Dow, S&P 500 Settle At Record High Levels, Record 6th Consecutive Week Of Gains: Fear Index Moves To 'Extreme Greed' Zone

The Procter &amp; Gamble Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pg#NYSE">PG</a>) issued its fiscal 2025 first-quarter earnings report on Friday, missing sales and net income estimates but topping adjusted profit estimates.&nbsp;
<h3>Fiscal First Quarter Highlights</h3>
For the quarter ended on September 30th, P&amp;G reported&nbsp;net sales&nbsp;dropped&nbsp;1% to $21.74 billion
Putting away&nbsp;&nbsp;foreign exchange, acquisitions and divestitures,&nbsp;organic revenue grew 2% helped by higher prices. However, volume was flat, which is a better reflection of sales. While in the U.S., P&amp;G&rsquo;s volume grew in eight of its 10 categories, Greater China&nbsp;told an entirely diferent story with both its hair care and oral care segments reporting volume declines.&nbsp;
Overall, health care and baby, feminine and family care divisions all reported 1% volume declines, the beauty business experienced a volume decline of 2%, while organic sales of the skin care segment tumbled more than 20%. Supported by innovation, grooming division was a rare bright spot with volume growth of 4%.&nbsp;Fabric and home care reported a mild volume rise of 1%.&nbsp;
Getting down to the bottom line, net income attributable to the company amounted to $3.96 billion, or $1.61 per share, with adjusted earnings per share amounting to $1.93 per share.
After several price hikes over the last few years, P&amp;G has seen demand for its products drop. The last quarter was the first time in more than two years that P&amp;G experienced an increase in volume, but it was apparently short-lived.&nbsp;With the falling&nbsp;global birth rate continues to drop, P&amp;G has been trying to push consumers to buy more expensive baby care items&nbsp;but organic sales of the baby care segment fell by mid-single digits as that strategy cannot always make up for the volume decline.&nbsp;
P&amp;G remains on track to deliver its guidance.
P&amp;G reiterated its fiscal 2025&nbsp;guidance, expecting revenue growth between&nbsp;2% and 4% and net earnings per share ranging from $6.91 to $7.05. But, P&amp;G CFO&nbsp;CFO Andre Schulten noted that the Chinese market will continue to be weak for quarters to come.&nbsp;The macroeconomic environment in the U.S. that accounts for almost half of total sales remains challenging with uncertainty pushing consumers to discount-offering rivals and cheaper brands. Its rival in packaged foods manufucating, Nestle S.A. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/nsrgy#OTC">NSRGY</a>) lowered its annual sales outlook. Nestle expects the weak demand environment to continue. After reporting dissapointing sales, Nestle announced changes corporate structure changes, aiming to streamline its operating structure. With the pandemic and the war in Ukraine, the packaged foods industry is not alone in struggling with soaring costs as prices of everything from raw materials to packaging continues to go through the roof. Even a Swiss giant like Nestle is dealing with a very painful and unprecedented reset as just like P&amp;G, it faces not only a demand slowdown&nbsp;but a significantly weakened consumer in the eyes of unprecedented uncertainty that has been lingering for quite some time, without any signs of going away.
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Nestle Sponsored representing Registered Shares Series B

NSRGY

Procter & Gamble Faces A Weakened Demand In Both The U.S. And China

Cantor Fitzgerald analyst Andres Sheppard initiates coverage on PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) with an Overweight<a target="_blank" href="https://www.benzinga.com/quote/pct/analyst-ratings" rel="noreferrer noopener"> rating and a price forecast of $14.</a>
According to the analyst, the company enjoys a differentiated technology and first-mover advantage, along with a large total addressable market (TAM) and the ability to scale up. It also benefits from a globally patented purification polypropylene recycling technology developed in partnership with Procter &amp; Gamble Company.
This FDA-approved technology employs a unique process that effectively removes odor and color from plastic waste, the analyst notes.
The analyst highlights that PureCycle plans to sell its UPR resin to a diverse array of customers across various industries, including consumer goods manufacturers and food and beverage producers.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings" rel="noreferrer noopener">Netflix &#8216;Should Continue To Outperform&#8217;: 6 Analysts On Streaming Stock&#8217;s Q3 Earnings</a>
Sheppard sees that the company&#8217;s first production line will reach near full capacity by 2025, with revenue reporting expected to begin in the second half of 2024.
The analyst mentions that the company is currently focused on expanding its second purification facility in Augusta, Georgia, which is expected to feature up to eight purification lines, each capable of producing approximately 130 million pounds annually.
The facility is projected to be operational by 2027, and Sheppard sees this will serve as a significant catalyst for growth.
Additionally, on September 11, the company strengthened its balance sheet by <a target="_blank" href="https://www.benzinga.com//node/40813616" rel="noreferrer noopener">raising $90 million in gross proceeds.</a>
Price Action: PCT shares are trading higher by 5.26% to $10.51 at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41402089/goldman-sachs-highlights-20-top-short-squeeze-opportunities-for-q3-earnings-season" target="_blank" rel="noreferrer noopener">Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season</a></li>
</ul>

Equities

Initiation

PureCycle Gains From First-Mover Advantage And Unique Recycling Technology, Analyst Highlights Expansionary Moves

Wall Street was in positive territory in Friday midday trading, buoyed by upbeat quarterly earnings reports that kept <a href="https://www.benzinga.com/markets">investor sentiment bullish.</a>
Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) surged 10% to fresh record highs after delivering a strong earnings beat. The tech-heavy Nasdaq 100 rose 0.8%, pushing its weekly performance into positive territory for the sixth consecutive week.
The S&amp;P 500 and Dow also edged higher, both on track for the sixth straight week of gains, with the Dow flirting with all-time highs.
Gold miners led industry performance as gold prices hit new record levels above $2,700 per ounce. The VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) soared over 4%, hitting the highest level in over four years. Friday is poised to mark the fourth straight session of gains for both gold and silver, with silver jumping over 3%, heading for its best day since late September.
West Texas Intermediate (WTI) crude prices tumbled more than 2%, slipping below the $70-per-barrel mark. WTI is down over 8% for the week, on pace for its worst weekly decline since January.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) climbed 2.8% to above $68,800.
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % change</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,352.25</td>
<td>0.8%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,870.75</td>
<td>0.5%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,300.82</td>
<td>0.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,279.45</td>
<td>-0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:55 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.5% to $585.12.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% higher to $433.01.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.8% to $495.21.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) stalled at $226.03.</li>
<li>The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) outperformed, up 0.9%. The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.6%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul>
<li>Stocks moving in reaction to earnings reports were Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), up over 9%, Crown Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>), up over 4%, Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>), down 6%, American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), down 2.4%, Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) down 0.4%, Schlumberger N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) down 3.3%, Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>), down 1.7%, Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), down 1% and Comerica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>), up 4%. </li>
<li>Lamb Weston Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) soared 10% following a report indicating that activist investor&nbsp;Jana Partners&nbsp;has built a 5% stake in the company.</li>
<li>CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) fell over 6% after the company replaced its CEO and cut its third-quarter outlook.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings">Netflix &#8216;Should Continue To Outperform&#8217;: 6 Analysts On Streaming Stock&#8217;s Q3 Earnings</a></li>
</ul>
Photo via Shutterstock.

Sector ETFs

Broad U.S. Equity ETFs

Treasuries

Econ #s

Tech

ETFs

$BTC

ALLY

SPDR Dow Jones Industrial Average ETF Trust

FITB

Market Vectors ETF Trust Market Vectors Gold Miners

Stocks Rise, Netflix Soars To Record Highs, Oil Falls Below $70, Gold Miners Rally: What's Driving Markets Friday?

P&G CFO Says Co Saw Stock-Up Situation As A Quick Run Up Due To The Port Strike Which Didn't Really Have A Material Impact On This Quarter; The Stock-Up Situation Due To Port Strikes Was Very Short-Lived

WIIM

Procter & Gamble shares are trading lower following a Q1 revenue miss.

Procter &amp; Gamble Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) shares are trading lower after the company reported&nbsp;first-quarter&nbsp;sales of&nbsp;$21.74 billion&nbsp;(-1% Y/Y),&nbsp;missing the analyst <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41399117/p-g-announces-fiscal-year-2025-first-quarter-results" rel="noreferrer noopener">consensus estimate of&nbsp;$21.91 billion</a>.
Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, increased&nbsp;by 2%.
Organic sales growth was driven by a 1% increase in higher pricing and a 1% rise in organic volume, excluding the effects of acquisitions and divestitures.
Sales in the Beauty segment fell&nbsp;5%, and the Baby, Feminine &amp; Family Care segment declined 2%.
Meanwhile, the Grooming segment sales sales remained flat, while Fabric &amp; Home Care grew 1% and Health Care sales increased&nbsp;2%.
Gross profit remained flat&nbsp;at $11.3 billion. The reported gross margin expanded by 10 basis points to&nbsp;52.1%, and the core gross margin was flat year-over-year.
Gains included 170 basis points from productivity savings and 30 basis points from pricing, offset by 90 basis points from higher commodity costs, 60 basis points from unfavorable mix, and 40 basis points from product reinvestments.
Operating margin expanded 30 basis points to&nbsp;26.7% while operating income for the quarter rose 1%&nbsp;to&nbsp;$5.80 billion.
Adjusted EPS of&nbsp;$1.93 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the analyst consensus of&nbsp;$1.90.</a>
P&amp;G held&nbsp;$12.16 billion&nbsp;in cash and equivalents as of September 30. Operating cash flow for the quarter was&nbsp;$4.3 billion.
The company returned around $4.4&nbsp;billion&nbsp;of value to shareholders via&nbsp;$2.4 billion&nbsp;in dividend payments and&nbsp;$1.9 billion&nbsp;of share repurchases.
&#8220;We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority — across product performance, packaging, brand communication, retail execution and consumer and customer value — productivity, constructive disruption and an agile and accountable organization,&#8221; said Board Chairman, President, and CEO Jon Moeller.
Outlook: P&amp;G reaffirmed FY25 guidance for all-in sales growth of&nbsp;2%&nbsp;–&nbsp;4%&nbsp;and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">organic sales growth of&nbsp;3%&nbsp;–&nbsp;5%</a>.
This&nbsp;outlook equates to FY25 revenue of&nbsp;$85.72 billion&nbsp;–&nbsp;$87.40 billion&nbsp;(versus an estimate of&nbsp;$86.06 billion) and adjusted EPS of&nbsp;$6.91&nbsp;–<a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/40037468/why-gillette-parent-procter-gamble-shares-are-tumbling-today" rel="noreferrer noopener"> $7.05&nbsp;(vs. consensus of $6.97)</a>.
P&amp;G reaffirmed its outlook for adjusted free cash flow productivity of&nbsp;90%, payment of around&nbsp;$10 billion in dividends and repurchasing&nbsp;$6 billion to&nbsp;$7 billion of common shares in fiscal 2025.
Investors can gain exposure to the stock via&nbsp;iShares U.S. Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYK#NYSE">IYK</a>) and Fidelity MSCI COnsumer Staples Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSTA#NYSE">FSTA</a>).
Price Action: PG shares are down 0.81% at $170.88 premarket at the last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41397178/procter-gamble-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earning" target="_blank" rel="noreferrer noopener">Procter &amp; Gamble Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Large Cap

Guidance

Dividends

Buybacks

FSTA

iShares Trust Dow Jones USnsumer Goods Sector Index Fund

Procter & Gamble's Mixed Bag Q1: EPS Exceeds Estimates, Reaffirms Growth Outlook & More

Previously, P&G maintained its guidance range for fiscal 2025 all-in sales growth to be in the range of 2%-4% versus the prior year, stating that t...

Procter & Gamble reiterates FY25 organic revenue growth view of 3%-5%

In slides for its investor day presentation, Procter & Gamble shared a long-term growth algorithm that includes organic sales to grow ahead of the ...

Procter & Gamble sees long-term core EPS growth in mid-to-high single digits

Proctor & Gamble continues gains for seven straight sessions

Procter & Gamble sees long-term organic sales growth beating market average

Wells Fargo analyst Christopher Carey maintained a Buy rating on Procter & Gamble (PG – Research Report) today and set a price target of $190.00. C...

Procter & Gamble: Strategic Positioning and Growth Opportunities Underpin Buy Rating

Evercore ISI analyst Robert Ottenstein maintained a Buy rating on Procter & Gamble (PG – Research Report) today and set a price target of $183.00. ...

Evercore ISI Sticks to Its Buy Rating for Procter & Gamble (PG)

Dow advances as Wall Street's key averages head toward weekly wins; Nasdaq slips

Dow, S&P advance as Wall Street's key averages head toward weekly wins

Stifel raised the firm's price target on Procter & Gamble to $167 from $165 and keeps a Hold rating on the shares after having attended P&G's inves...

Procter & Gamble price target raised to $167 from $165 at Stifel

Dow climbs 1%, S&P, Nasdaq advance as Wall Street's key averages cement weekly wins

NVDA

ROST

Screenshot 2024-09-30 at 5.38.54 PM

Biotech

Movers & Shakers

COSM

VTRS

How Cosmos Health&#39;s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

Comments

Procter & Gamble

空売り

Procter & Gamble (NYSE:PG) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル